Vontobel Financial Products GmbH (F18533) Quote

liquidation break
market coming back
gold dumped looks like buy

My strategy - discuss only. More On - you're the one boasting about your timely sells and buys. Can't wait until this goes below the .0050!

"The recent expectation of the prior decline as a corrective 4th wave has proven out..........."

http://www.pretzelcharts.com/

" So, the chart pretty much speaks for itself again.
"
blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiXSA8Cn2EiZpUVAEVVu8b9X

I agree, he doesn't have control over the legacy d holders. And I hope all is done now. The future still looks great here.

However the hard data, NOT opinion, show high WV dependency on the Federal gov, low GDP and generally low rankings for the economy, health & education, suggesting that their votes for the GOP are just another version of cutting off your nose to spite your face.

Dems opinion of this

Don't agree with your timelines, I'd say add 30 days to MHRA approval, add 60 days to Nice approval, add 90 days $250M cash infusion.

I think your MHRA approval price bump is too optimistic.

Conversely, I think NICE reimbursement is worth way more than $0.50.

I don't know but ensitrelvir suffers from DDIs much like paxlovid and EDP-235 doesn't so even if it were to gain approval in the west (more of an uphill battle after the recent phase 3 readout), EDP-235 should still have appeal based on DDI alone. This is why shionogi is bringing forward another PI

It will open post split at $140

June 6th....I will not retire until I have put assets into all the companies, which I am actively working on. Unfortunately, the bad actors in this business have made it a challenge to find LEGITIMATE companies to list on the OTC. I won't deal with pretend companies like $CYBL $OPTI $FLES $SIRC $I

Start !

BRING THE NOISE!!!

imho
mj

$MMA - Alta Global Group (NYSE American:MMA) announces significant partnership with legendary MMA coach Eric Nicksick, renowned for guiding three fighters to UFC championships, including Francis Ngannou, Aljamain Sterling, and Sean Strickland.

This big announcement is set to deepen A

$MMA - Alta Global Group (NYSE American:MMA) announces significant partnership with legendary MMA coach Eric Nicksick, renowned for guiding three fighters to UFC championships, including Francis Ngannou, Aljamain Sterling, and Sean Strickland.

This big announcement is set to deepen A

$MMA - Alta Global Group (NYSE American:MMA) announces significant partnership with legendary MMA coach Eric Nicksick, renowned for guiding three fighters to UFC championships, including Francis Ngannou, Aljamain Sterling, and Sean Strickland.

This big announcement is set to deepen A

$MMA - Alta Global Group (NYSE American:MMA) announces significant partnership with legendary MMA coach Eric Nicksick, renowned for guiding three fighters to UFC championships, including Francis Ngannou, Aljamain Sterling, and Sean Strickland.

This big announcement is set to deepen A

I just read CELU and their incredible drop after merging with the honest GX group. That was the worst outcome of a SPAC merger I have ever laid eyes on. Niocorp is on par with this company. Stock went from over ten bucks a share post GX to having to do a PP at 24.9 cents with some Asian guy or they

Results still will need analyzed and they don't have money to start now. Need money for new engineering too which is to happen concurrently.

These morons can't justify why on election night 2020 that on the LIVE feeds from MSM, Trump votes counter magically decreased and Biden votes increased by the exact same amount. No one can justify a vote counter decreasing in votes. It's all on video. LOL

Not too mention that for e

I gotcha.

Your second to last paragraph…

LWLG isn’t playing catch up. If you’re referring to TFLN, yes more people are using it right now, but in no way is LWLG “behind” in terms of development.

LWLG is ahead from a mass manufacturing standpoint and even

you sure spend alot of time and effort on a scam ,go out ang et drunk and get some pusse***,get a life,go have some fun

$OCX Last week, Oncocyte announced positive data results for its flagship diagnostic product, VitaGraft™.

In a phase 2 double-blind, placebo-controlled study (NCT05021484), VitaGraft Kidney was used to monitor graft injury associated with the investigational drug felzartamab, a fully

$OCX Last week, Oncocyte announced positive data results for its flagship diagnostic product, VitaGraft™.

In a phase 2 double-blind, placebo-controlled study (NCT05021484), VitaGraft Kidney was used to monitor graft injury associated with the investigational drug felzartamab, a fully

$OCX Last week, Oncocyte announced positive data results for its flagship diagnostic product, VitaGraft™.

In a phase 2 double-blind, placebo-controlled study (NCT05021484), VitaGraft Kidney was used to monitor graft injury associated with the investigational drug felzartamab, a fully